Insights Center

Thought leadership, news, events — you will find them all here, right at your fingertips. We’ve consolidated the firm’s most popular content in one, easy to search location. Enter a key word or phrase to find pertinent blog posts, articles, press releases, and upcoming events.

Featured

Mintz Direct

On our new Mintz Direct page, Mintz thought leaders across industries and practice areas offer timely insights on developments that impact our clients and communities. Visit the Mintz Direct page to hear what our experienced attorneys and professionals are saying about what’s happening now.

Mintz Viewpoints

Use quotation marks to search for an exact phrase (e.g. “class action”)

Published

Showing 6609 - 6616 of 12004 results

OTC Drug Manufacturers: Keep Your Eyes and Ears on Congress

October 10, 2017| Blog| Viewpoint

Building a Health App? Part 4: Avoiding an FTC Enforcement Action

October 10, 2017| Blog| Viewpoint

Department of Veterans Affairs Aims to Trump State Telemedicine Rules

October 10, 2017| Blog| Viewpoint

Health Care Weekly Preview from ML Strategies – Week of October 9, 2017

October 10, 2017| Blog| Viewpoint

InsureTech Connect 2017 Panel Discussion: Maximizing Profits via Products and Alternative Business Model Innovation

October 9, 2017| Article| Viewpoint

Federal Trade Commission Announces Workshop on Competition in the Prescription Drug Market

October 9, 2017| Blog| Viewpoint

General Plastic Industrial Co. v. Canon Kabushiki Kaisha: PTAB Explains Factors for Follow-On Petitions

October 9, 2017| Blog| Viewpoint

CPSC Round-Up: Buerkle Confirmation Hearing, Landmark Civil Penalty Ruling, and Partisan Action on Flame Retardants

October 6, 2017| Blog| Viewpoint

News & Press Releases

Mintz Advises Syntis Bio on $33 Million Series A Financing

July 02, 2025

Mintz advised Syntis Bio, a clinical-stage biopharmaceutical company revolutionizing oral therapies for obesity, diabetes, and rare diseases, on a $33 million oversubscribed Series A financing.

Mintz Obtains Trademark TRO Against OpenAI on Behalf of IYO, Inc.

June 30, 2025

Mintz secured a rare trademark temporary restraining order (TRO) on behalf of IYO, Inc. against OpenAI, Sam Altman, Sir Jony Ive, and IO Products, Inc. The order temporarily bars the defendants from using the trademark associated with their new product launch.

Mintz Advises Brij in $8M Oversubscribed Funding Round

June 26, 2025

Mintz advised Brij—a software platform enhancing the consumer experience by bridging online and offline commerce—on the closing of its $8 million Series Seed round. The funding will help Brij advance its mission to close the trillion-dollar disconnect between brands and their retail customers and power the next generation of offline-to-online customer relationships.

View all News and Press Releases